With the Macroeconomic Environment Improving, these Three Biotech Stocks Are Worth Watching May 21, 2026 Life Science
Dyne Therapeutics Stock Rises 40% in a Year, but Saturn V Fund Reduces Holdings May 20, 2026 Life Science
Eli Lilly Stock Hits Bottleneck After 400% Surge in Five Years, Novo Nordisk Poised for a Comeback with 4% Dividend Yield May 8, 2026 Life Science
Dark Horse in the Weight-Loss Drug Arena? Viking Therapeutics Has Potential Upside of Over 200% May 4, 2026 Life Science
From Weight Loss to Cancer Treatment Drugs, Eli Lilly Has More Than One Ace in the Hole Apr 28, 2026 Life Science
